Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, 14 University Dr, Robina, QLD, 4229, Australia.
Australian Commission on Safety and Quality in Health Care, Sydney, NSW, Australia.
BMC Fam Pract. 2021 Jan 19;22(1):24. doi: 10.1186/s12875-021-01369-0.
Overuse of proton pump inhibitors (PPIs) - frequently used for relieving symptoms of gastroesophageal reflux disease (GORD) - raises long-term safety concerns, warranting evidence-based non-drug interventions. We conducted a systematic review to evaluate the effect of head-of-bed elevation on relieving symptoms of GORD in adults.
We included controlled trials comparing the effect of head-of-bed elevation interventions to control in adults with GORD. Two independent reviewers screened articles, extracted data, and assessed quality of included studies. Primary outcomes were changes in GORD symptoms and use of PPIs.
We screened 1206 records; and included five trials (four cross-over and one factorial) comprising 228 patients. All five included trials were judged to be at high-risk of performance bias and four of selection bias. Of five included trials, two used 'bed blocks' under the bed legs; one used 'sleeping on a wedge' pillow, and two used both. High heterogeneity in outcome measures and reported outcomes data precluded meta-analyses. The four studies that reported on GORD symptoms found an improvement among participants in the head-of-bed elevation; a high-quality crossover trial showed a clinical important reduction in symptom scores at 6 weeks (risk ratio of 2.1; 95% CI 1.2 to 3.6). These results are supported by the observed improvement in physiological intra-oesophageal pH measurements.
Methodological and reporting limitations in available literature preclude definitive recommendations. However, head-of-bed elevation could be still considered as a cheap and safe alternative to drug interventions with unfavourable safety profiles.
Open Science Framework: http://osf.io/2hz3j.
质子泵抑制剂(PPIs)被广泛用于缓解胃食管反流病(GORD)的症状,但过度使用此类药物会引发长期安全性问题,因此需要寻找基于证据的非药物干预方法。本系统评价旨在评估床头抬高对成人 GORD 症状缓解的效果。
我们纳入了比较床头抬高干预与对照在 GORD 成人患者中的效果的对照试验。两位独立的综述作者筛选文章、提取数据并评估纳入研究的质量。主要结局指标为 GORD 症状的变化和 PPI 的使用情况。
我们筛选了 1206 条记录,纳入了 5 项试验(4 项交叉试验和 1 项析因试验),共 228 名患者。所有 5 项纳入试验均被认为存在高度偏倚风险,其中 4 项存在选择偏倚,5 项纳入试验中有 2 项使用了床腿下的“床挡”,1 项使用了“楔形枕头”,2 项同时使用了这两种方法。由于结局测量和报告结果数据存在高度异质性,因此无法进行荟萃分析。4 项报告 GORD 症状的研究均发现床头抬高组患者的症状有所改善;一项高质量的交叉试验显示,6 周时症状评分有临床意义的降低(比值比 2.1;95%CI 1.2 至 3.6)。这些结果得到了食管内生理 pH 测量改善的支持。
现有文献的方法学和报告局限性限制了明确的推荐。然而,床头抬高仍可被视为一种具有成本效益且安全的替代药物干预措施,特别是对于那些安全性较差的药物。
开放科学框架:http://osf.io/2hz3j。